Ethyl 5,5-Dimethyl-2,4-dioxohexanoate, 97.0%, 100g

(3R,4R,5R)-6-(((2S,3R,4S,5S,6R)-3,4,5-Trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)hexane-1,2,3,4,5-pentaol, 97.0%, 500g

Sodium hypochlorite solution, 5-10% Cl, techn., 10 l, plastic packaging.

Fmoc-�-HoVal-OH, 95%, 25g

[3-(3-methoxyphenyl)-1,2,4-oxadiazol-5-yl]methanamine, 95.0%, 2g

2-(Piperidin-4-ylmethyl)pyrimidine, 98%, 100mg

(R)-2-Amino-2-methyldec-9-enoic acid, 97%, 1g

Methyl 2-(4-nitrophenyl)oxazole-4-carboxylate, 95.0%, 250mg

4-Bromo-2-hydroxybenzonitrile, 98.0%, 25g

2-(2,5-Dimethylbenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 5g

(2-Methoxynaphthalen-1-yl)boronic acid, 95.0%, 5g

4-Bromo-2-hydroxyphenylboronic acid, 98+%, 1g

(2E)-1,3-bis(3-bromophenyl)prop-2-en-1-one, 95.0%, 2g